Part 2070: SCHEDULE OF CONTROLLED SUBSTANCES

Section 2070.1425 Pentobarbital Pentobarbital

Section 2070.1430 Phencyclidine Phencyclidine

Section 2070.1435 Pentazocine Pentazocine

Section 2070.1438 Gluthethimide Gluthethimide (Source: Renumbered from 2070.1835 at 8 Ill. Reg. 13138, effective July 27, 1984)

Section 2070.145 Alpha-methylfentanyl Alpha-methylfentanyl (N-(l-alpha-methyl-beta-phenyl)ethyl-4-piperidyl) propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) (Source: Amended at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.146 Alpha-methylthiofentanyl Alpha-methylthiofentanyl (N-[1-menthyl-2-(2-thienyl) ethyl-4-piperideinyl]-N- phenylpropanamide) (Source: Added at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.147 1-methyl-4-phenyl-4-propionoxypiperdine (MPPP) 1-methyl-4-phenyl-4-propionoxypiperdine (MPPP) (Source: Added at 10 Ill. Reg. 11222, effective June 16, 1986)

Section 2070.148 PEPAP 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine PEPAP 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine) (Source: Amended at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.150 Benzethidine Benzethidine

Section 2070.1500 Immediate Precursors Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1505 to 2070.1510.

Section 2070.1505 Amphetamine and Methamphetamine Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.

Section 2070.1510 Phencyclidine Immediate precursors to phencyclidine. a) 1-phenylcyclohexylamine b) 1-piperidinocyclohexanecarbonitrile (PCC).

Section 2070.1520 Nabilone Nabilone (Source: Added at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.155 Betacetylmethadol Betacetylmethadol

Section 2070.1550 Dronabinol (oral solution) Dronabinol (oral solution) and other names: (6aR, 10aR)-6a,7,8,10a-tetrahydro-6,6,9- trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-o1. (Source: Amended at 45 Ill. Reg. 13018, effective October 4, 2021) SUBPART D: SCHEDULE OF CONTROLLED SUB…

Section 2070.157 Beta-hydroxyfentanyl Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide) (Source: Added at 20 Ill. Reg 3081, effective February 2, 1996)

Section 2070.160 Betameprodine Betameprodine

Section 2070.1600 Schedule III − Criteria The Department finds that the substances enumerated in Schedule III following meet the criteria established in Section 207 of the Act.

Section 2070.1605 Schedule III − Enumeration The controlled substances listed in these Sections 2070.1615 to 2070.2000 are included in Schedule III.

Section 2070.1610 Stimulants Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1615 to 2070.1640 having s stimulant effect on the central nervous…

Section 2070.1615 Excepted Compounds Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 21 CFR 308.32, and …

Section 2070.1620 Benzphetamine Benzphetamine

Section 2070.1625 Chlorphentermine Chlorphentermine

Section 2070.1630 Clortermine Clortermine

Section 2070.1635 Mazindol (Renumbered) Mazindol (Source: Renumbered to Section 2070.2540 at 6 Ill. Reg. 7200, effective June 7, 1982)

Section 2070.1640 Phendimetrazine Phendimetrazine

Section 2070.165 Betamethadol Betamethadol

Section 2070.170 Betaprodine Betaprodine

Section 2070.1700 Other Stimulants Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the substances listed in Section 2070.1750 having a potential for abuse associated with a stimulant …

Section 2070.175 Clonitazene Clonitazene

Section 2070.1750 Methylphenidate (Renumbered) (Source: Former Section 2070.1750 renumbered to Section 2070.1330 at 20 Ill. Reg. 3081, effective February 2, 1996)

Section 2070.180 Dextromoramide Dextromoramide

Section 2070.1800 Depressants Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the substances listed in Sections 2070.1805 to 2070.1875 having a potential for abuse associated with a …

Section 2070.1805 Barbiturates Any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital, or any salt of any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.

Section 2070.1810 Barbiturates − Suppository Dosage Form Any suppository dosage form containing amobarbital, secobarbital, pentobarbital or any salt of any of these drugs and approved by the Federal Food and Drug Administration for marketing only as a suppository.

Section 2070.1825 Derivatives of Barbituric Acid Any substance which contains any quantity of a derivative of barbituric acid, or any salt thereof.

Section 2070.1830 Chlorhexadol Chlorhexadol

Section 2070.1835 Glutethimide Glutethimide (Source: Renumbered to 2070.1438 at 8 Ill. Reg. 13135, effective July 27, 1984)

Section 2070.1840 Methyprylon Methyprylon

Section 2070.1845 Sulfondiethylmethane Sulfondiethylmethane

Section 2070.185 Diampromide Diampromide

Section 2070.1850 Sulfonethylmethane Sulfonethylmethane

Section 2070.1855 Sulfonmethane Sulfonmethane

Section 2070.1860 Lysergic Acid Lysergic acid

Section 2070.1865 Lysergic Acid Amide Lysergic acid amide

Section 2070.1868 Tiletamine or Zolazepam or Both Tiletamine or zolazepam or both, or any salt of either of them. Some trade or other names for a tiletamine-zolazepam combination product: Telazol. Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)- cyclohexano…

Section 2070.1870 Pentazocine and Aspirin Compound Any material, compound, mixture or preparation containing not more than 12.5 milligrams of pentazocine or any of its salts, per 325 milligrams of aspirin.